Low Dose Naltrexone (LDN) is a prescription therapy increasingly utilized as an adjunctive support tool for weight management and metabolic health. While traditionally used for pain and autoimmune conditions, LDN is prescribed under medical supervision to help modulate appetite signaling, reduce systemic inflammation, and improve insulin sensitivity.

At low doses, naltrexone temporarily blocks opioid receptors, triggering a rebound increase in the body’s natural endorphin production. These endorphins play a role in regulating mood, stress response, and appetite control. By enhancing endorphin levels, LDN may help reduce food cravings associated with stress and emotional eating. Additionally, by lowering chronic inflammation and improving cellular insulin sensitivity, LDN supports a metabolic environment more conducive to fat utilization. Results are dependent on concurrent diet and exercise.